Assessment of structural behaviour of new L-asparaginase and SAXS data-based evidence for catalytic activity in its monomeric form

Abstract

ABSTRACTThe present study reports the structural and functional characterization of a new glutaminase-free recombinant L-asparaginase (PrASNase) from Pseudomonas resinovorans IGS-131. PrASNase showed substrate specificity to L-asparagine, and its kinetic parameters, Km, Vmax, and kcatwere 9.49×10-3M, 25.13 IUmL-1min-1, and 3.01×103s-1, respectively. The CD spectra showed that PrASNase consists of 30.9% α-helix and 69.1% other structures in its native form. FTIR was used for the functional characterization, and molecular docking predicted that the substrate interacts with serine, alanine, and glutamine in the binding pocket of PrASNase. Different from known asparaginases, structural characterization by small-angle X-ray scattering (SAXS) and analytical ultracentrifugation (AUC) unambiguously revealed PrASNase to exist as a monomer in solution at low temperatures and oligomerized to a higher state with temperature rise. Through SAXS studies and enzyme assay, PrASNase was found to be mostly monomer and catalytically active at 37°C. Furthermore, this glutaminase-free PrASNase showed killing effects against WIL2-S and TF-1.28 cells with IC50of 7.4 µg.mL-1and 5.6 µg.mL-1, respectively. This is probably the first report with significant findings of fully active L-asparaginase in monomeric form using SAXS and AUC and demonstrates the potential of PrASNase in inhibiting cancerous cells, making it a potential therapeutic candidate.HIGHLIGHTSA new L-asparaginase (PrASNase) was structurally and functionally characterized.SAXS revealed PrASNase is functionally active in monomeric form and oligomerizes with temperature rise.Monomeric PrASNase showed an IC50value of 7.4 and 5.6 µg mL-1against WIL2-S and TF-1.28 cells.Cytotoxicity of PrASNase against leukemic cell lines showed its potential as a biotherapeutic.GRAPHICAL ABSTRACT